GlassScriptPhysician profile
Michael Paul Busch
NPI 1124426572
$23,770.04
in general payments reported to CMS, 2019-2025
7 companies · $5,414 in 2025
The $5,414 reported for 2025 was more than what 85% of Clinical Pathology/Laboratory Medicine providers received nationally (typical 2025 total: $114).
See the full distribution for Clinical Pathology/Laboratory Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,110 · 2020: $24.51 · 2021: $1,774 · 2022: $4,655 · 2023: $8,793 · 2025: $5,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,850 · Travel and Lodging: $311 · Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,930.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,850.00 |
| Travel and Lodging | $310.54 |
| Food and Beverage | $115.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14,242.50 | 2021-2025 | |
| Grifols Diagnostic Solutions, INC. | $3,243.72 | 2019-2025 | |
| Ortho-Clinical Diagnostics, INC. | $3,061.67 | 2021-2022 | |
| Roche Molecular Systems, INC. | $2,023.05 | 2019-2025 | |
| Gen-Probe, INC. | $1,070.32 | 2019-2022 | |
| Cerus Corporation | $86.05 | 2019 | |
| Hologic Sales and Service, LLC | $42.73 | 2023 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Busch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.